Stay updated with breaking news from Dynamic Precision Library. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
SAN DIEGO and SUZHOU, China, May 22, 2024 (GLOBE NEWSWIRE) -- Adagene Inc. ("Adagene") (NASDAQ:ADAG), a company transforming the discovery and development of novel antibody-based therapies, today announced its
- Data for masked anti-CTLA-4 SAFEbody® ADG126 highlight best-in-class therapeutic index and demonstrate clinical benefits in metastatic microsatellite-stable colorectal cancer with higher, more...
SAN DIEGO and SUZHOU, China, Feb. 27, 2024 -- Adagene Inc. , a company transforming the discovery and development of novel antibody-based therapies, today announced its participation in the...
- Interim data from additional MSS CRC patients dosed at 10 mg/kg every three weeks in combination with pembrolizumab anticipated in 2024 at a medical conference - - Initiated evaluation of...
Adagene Inc. ("Adagene") (Nasdaq: ADAG), a company transforming the discovery and development of novel antibody-based therapies, today announced data from its ...